In certain other types of tumors, e.g., subtypes of renal clear cell carcinoma and cases of sporadic paraganglioma, HIF2α is a well-studied oncogenic driver of the disease (4) and a similar role for HIF2α has been suggested in neuroblastoma (5). This evidence concerns the gene EPAS1 and neuroblastoma.